Abvc Biopharma (ABVC) Notes Payables (2016 - 2025)
Historic Notes Payables for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to $809103.0.
- Abvc Biopharma's Notes Payables fell 972.35% to $809103.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $809103.0, marking a year-over-year decrease of 972.35%. This contributed to the annual value of $840252.0 for FY2024, which is 656.08% down from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's Notes Payables is $809103.0, which was down 972.35% from $871951.0 recorded in Q2 2025.
- In the past 5 years, Abvc Biopharma's Notes Payables ranged from a high of $1.9 million in Q4 2022 and a low of $801407.0 during Q1 2025
- Moreover, its 5-year median value for Notes Payables was $902000.0 (2023), whereas its average is $1.2 million.
- In the last 5 years, Abvc Biopharma's Notes Payables surged by 6152.5% in 2021 and then crashed by 5432.02% in 2023.
- Quarter analysis of 5 years shows Abvc Biopharma's Notes Payables stood at $1.6 million in 2021, then increased by 15.47% to $1.9 million in 2022, then crashed by 52.51% to $899250.0 in 2023, then fell by 6.56% to $840252.0 in 2024, then fell by 3.71% to $809103.0 in 2025.
- Its Notes Payables stands at $809103.0 for Q3 2025, versus $871951.0 for Q2 2025 and $801407.0 for Q1 2025.